BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34755660)

  • 1. [Peripheral blood
    Zhou X; Lei S; Li L; Xu T; Gu W; Ma F; Yang R
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Oct; 41(10):1456-1463. PubMed ID: 34755660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RPTOR methylation in the peripheral blood and breast cancer in the Chinese population.
    Yin Y; Lei S; Li L; Yang X; Yin Q; Xu T; Zhou W; Li H; Gu W; Ma F; Yang R; Zhang Z
    Genes Genomics; 2022 Apr; 44(4):435-443. PubMed ID: 34767153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between RAPSN methylation in peripheral blood and breast cancer in the Chinese population.
    Lei S; Li L; Yang X; Yin Q; Xu T; Zhou W; Gu W; Ma F; Yang R
    J Hum Genet; 2021 Nov; 66(11):1069-1078. PubMed ID: 33958711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between
    Li J; Zhou X; Li L; Ji L; Li J; Qu Y; Wang Z; Zhao Y; Zhang J; Liang F; Liu J; Gu W; Yang R; Ma F; Dai L
    Front Oncol; 2023; 13():1148635. PubMed ID: 37274256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection and clinical significance of Notch1 methylation in breast cancer and intraductal proliferative breast lesions].
    Zhang N; Sun ZZ; Li F; Cao YW; Zhao CX; Liang WH; Sun HP; Li HA; Fu XG
    Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):324-9. PubMed ID: 21756827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Association Between Breast Cancer and Blood-Based Methylation of
    Liu C; Zhou X; Jin J; Zhu Q; Li L; Yin Q; Xu T; Gu W; Ma F; Yang R
    Front Genet; 2022; 13():927519. PubMed ID: 35812748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between breast cancer and S100P methylation in peripheral blood by multicenter case-control studies.
    Yang R; Stöcker S; Schott S; Heil J; Marme F; Cuk K; Chen B; Golatta M; Zhou Y; Sutter C; Wappenschmidt B; Schmutzler R; Bugert P; Qu B; Bartram CR; Sohn C; Schneeweiss A; Burwinkel B
    Carcinogenesis; 2017 Mar; 38(3):312-320. PubMed ID: 28426874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation array analyses identified breast cancer-associated HYAL2 methylation in peripheral blood.
    Yang R; Pfütze K; Zucknick M; Sutter C; Wappenschmidt B; Marme F; Qu B; Cuk K; Engel C; Schott S; Schneeweiss A; Brenner H; Claus R; Plass C; Bugert P; Hoth M; Sohn C; Schmutzler R; Bartram CR; Burwinkel B
    Int J Cancer; 2015 Apr; 136(8):1845-55. PubMed ID: 25213452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
    Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation array analysis identifies breast cancer associated RPTOR, MGRN1 and RAPSN hypomethylation in peripheral blood DNA.
    Tang Q; Holland-Letz T; Slynko A; Cuk K; Marme F; Schott S; Heil J; Qu B; Golatta M; Bewerunge-Hudler M; Sutter C; Surowy H; Wappenschmidt B; Schmutzler R; Hoth M; Bugert P; Bartram CR; Sohn C; Schneeweiss A; Yang R; Burwinkel B
    Oncotarget; 2016 Sep; 7(39):64191-64202. PubMed ID: 27577081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single CpG hypermethylation, allele methylation errors, and decreased expression of multiple tumor suppressor genes in normal body cells of mutation-negative early-onset and high-risk breast cancer patients.
    Böck J; Appenzeller S; Haertle L; Schneider T; Gehrig A; Schröder J; Rost S; Wolf B; Bartram CR; Sutter C; Haaf T
    Int J Cancer; 2018 Sep; 143(6):1416-1425. PubMed ID: 29659014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DOK7 CpG hypermethylation in blood leukocytes as an epigenetic biomarker for acquired tamoxifen resistant in breast cancer.
    Gowdini E; Aleyasin SA; Ramezani N; Nafisi N; Tutuni M
    J Hum Genet; 2023 Jan; 68(1):33-38. PubMed ID: 36372800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Association Between Breast Cancer and Blood-Based Methylation of
    Yin Q; Yang X; Li L; Xu T; Zhou W; Gu W; Ma F; Yang R
    Front Genet; 2020; 11():977. PubMed ID: 33005177
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Zang Z; Yin Y; Liu C; Zhu Q; Huang X; Li H; Yang R
    Epigenetics; 2024 Dec; 19(1):2352683. PubMed ID: 38723244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation profiles of 22 candidate genes in breast cancer using high-throughput MALDI-TOF mass array.
    Radpour R; Kohler C; Haghighi MM; Fan AX; Holzgreve W; Zhong XY
    Oncogene; 2009 Aug; 28(33):2969-78. PubMed ID: 19503099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined Detection of HER2, Ki67, and GSTP1 Genes on the Diagnosis and Prognosis of Breast Cancer.
    Song B; Wang L; Zhang Y; Li N; Dai H; Xu H; Cai H; Yan J
    Cancer Biother Radiopharm; 2019 Mar; 34(2):85-90. PubMed ID: 30585764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Peripheral blood
    Zang Z; Qiao R; Zhu Q; Zhou X; Gu W; Han B; Yang R
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Mar; 43(3):349-359. PubMed ID: 37087578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation of progesterone receptor isoform A promoter in normal breast tissue: An epigenetic link between early age at menarche and risk of breast cancer?
    Daraei A; Izadi P; Khorasani G; Nafissi N; Naghizadeh MM; Younosi N; Meysamie A; Mansoori Y; Nariman-Saleh-Fam Z; Bastami M; Saadatian Z; Zendehbad Z; Tavakkoly-Bazzaz J
    J Cell Biochem; 2019 Aug; 120(8):12393-12401. PubMed ID: 30816620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation and hormone receptor status in breast cancer.
    Benevolenskaya EV; Islam AB; Ahsan H; Kibriya MG; Jasmine F; Wolff B; Al-Alem U; Wiley E; Kajdacsy-Balla A; Macias V; Rauscher GH
    Clin Epigenetics; 2016; 8():17. PubMed ID: 26884818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CpG island methylation profile of estrogen receptor alpha in Iranian females with triple negative or non-triple negative breast cancer: new marker of poor prognosis.
    Ramezani F; Salami S; Omrani MD; Maleki D
    Asian Pac J Cancer Prev; 2012; 13(2):451-7. PubMed ID: 22524805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.